Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial

BACKGROUND: Intrauterine infection and/or inflammation (Triple I) is an important cause of preterm birth (PTB) and adverse newborn outcomes. N-acetylcysteine (NAC) is a Food and Drug Administration (FDA)-approved drug safely administered to pregnant women with acetaminophen toxicity. METHODS: We con...

Descripción completa

Detalles Bibliográficos
Autores principales: Buhimschi, Catalin S., Bahtiyar, Mert Ozan, Zhao, Guomao, Abdelghany, Osama, Schneider, Lydia, Razeq, Sonya Abdel, Dulay, Antonette T., Lipkind, Heather S., Mieth, Saya, Rogers, Lynette, Bhandari, Vineet, Buhimschi, Irina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451831/
https://www.ncbi.nlm.nih.gov/pubmed/32818949
http://dx.doi.org/10.1038/s41390-020-01106-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451831/
https://www.ncbi.nlm.nih.gov/pubmed/32818949
http://dx.doi.org/10.1038/s41390-020-01106-w

Ejemplares similares